Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Spineway SAS Receives Chinese FDA Certification for Its Intervertebral Cages


Friday, 12 Jul 2013 11:45am EDT 

Spineway SAS announced that its intervertebral cages were certified by the Chinese Food and Drug Administration. 

Company Quote

6.5
0.0 +0.00%
30 Jan 2015